» Articles » PMID: 35170821

Classifying Atopic Dermatitis: a Systematic Review of Phenotypes and Associated Characteristics

Overview
Date 2022 Feb 16
PMID 35170821
Authors
Affiliations
Soon will be listed here.
Abstract

Atopic dermatitis is a heterogeneous disease, accompanied by a wide variation in disease presentation and the potential to identify many phenotypes that may be relevant for prognosis and treatment. We aimed to systematically review previously reported phenotypes of atopic dermatitis and any characteristics associated with them. Ovid EMBASE, Ovid MEDLINE and Web of Science were searched from inception till 12 February 2021 for studies attempting to classify atopic dermatitis. Primary outcomes are atopic dermatitis phenotypes and characteristics associated with them in subsequent analyses. A secondary outcome is the methodological approach used to derive them. In total, 8511 records were found. By focussing only on certain clinical phenotypes, 186 studies were eligible for inclusion. The majority of studies were hospital-based (59%, 109/186) and cross-sectional (76%, 141/186). The number of included patients ranged from seven to 526 808. Data-driven approaches to identify phenotypes were only used in a minority of studies (7%, 13/186). Ninety-one studies (49%) investigated a phenotype based on disease severity. A phenotype based on disease trajectory, morphology and eczema herpeticum was investigated in 56 (30%), 22 (12%) and 11 (6%) studies respectively. Thirty-six studies (19%) investigated morphological characteristics in other phenotypes. Investigated associated characteristics differed between studies. In conclusion, we present an overview of phenotype definitions used in literature for severity, trajectory, morphology and eczema herpeticum, including associated characteristics. There is a lack of uniform and consistent use of atopic dermatitis phenotypes across studies.

Citing Articles

Novel drug delivery systems in topical treatment of atopic dermatitis.

Dabhadkar M, Kulkarni M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40080153 DOI: 10.1007/s00210-025-04002-4.


Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata-A Small Retrospective Cohort Study.

Branisteanu D, Hutanu A, Branisteanu D, Colac-Botoc C, Ciobanu R, Munteanu C Diagnostics (Basel). 2025; 15(5).

PMID: 40075768 PMC: 11899721. DOI: 10.3390/diagnostics15050520.


Predictors for the Efficacy of 4-Week Dupilumab Treatment in Atopic Dermatitis Patients.

Yu L, Lian C, Li L, Li J, Zhang S J Asthma Allergy. 2025; 18:331-337.

PMID: 40061429 PMC: 11890359. DOI: 10.2147/JAA.S508697.


PeiTuQingXin formula alleviated atopic dermatitis symptoms via inhibiting TRADD/TRAF2/RIP1 complex mediated NF-κB signaling pathway activation.

Cheng Z, Ma X, Luo F, Mo X, Liu J, Chen D Arch Dermatol Res. 2025; 317(1):535.

PMID: 40056166 PMC: 11890400. DOI: 10.1007/s00403-025-03998-2.


Counselling Needs in Atopic Dermatitis: Perspectives on Pregnancy and Treatment.

Skovsgard C, Frolunde A, Deleuran M, Thyssen J, Thyssen J, Thomsen S Acta Derm Venereol. 2025; 105:adv42544.

PMID: 40052706 PMC: 11904633. DOI: 10.2340/actadv.v105.42544.


References
1.
Nowrouzian F, Ljung A, Nilsson S, Hesselmar B, Adlerberth I, Wold A . Neonatal gut colonization by Staphylococcus aureus strains with certain adhesins and superantigens is negatively associated with subsequent development of atopic eczema. Br J Dermatol. 2018; 180(6):1481-1488. DOI: 10.1111/bjd.17451. View

2.
Silverwood R, Forbes H, Abuabara K, Ascott A, Schmidt M, Schmidt S . Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study. BMJ. 2018; 361:k1786. PMC: 6190010. DOI: 10.1136/bmj.k1786. View

3.
Yew Y, Thyssen J, Silverberg J . A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics. J Am Acad Dermatol. 2018; 80(2):390-401. DOI: 10.1016/j.jaad.2018.09.035. View

4.
von Kobyletzki L, Bornehag C, Breeze E, Larsson M, Lindstrom C, Svensson A . Factors associated with remission of eczema in children: a population-based follow-up study. Acta Derm Venereol. 2013; 94(2):179-84. DOI: 10.2340/00015555-1681. View

5.
Lou C, Mitra N, Wubbenhorst B, DAndrea K, Hoffstad O, Kim B . Association between fine mapping thymic stromal lymphopoietin and atopic dermatitis onset and persistence. Ann Allergy Asthma Immunol. 2019; 123(6):595-601.e1. PMC: 6878172. DOI: 10.1016/j.anai.2019.08.018. View